12-13570458-T-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000834.5(GRIN2B):​c.2172-441A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.515 in 152,052 control chromosomes in the GnomAD database, including 20,942 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.51 ( 20942 hom., cov: 33)

Consequence

GRIN2B
NM_000834.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.21

Publications

5 publications found
Variant links:
Genes affected
GRIN2B (HGNC:4586): (glutamate ionotropic receptor NMDA type subunit 2B) This gene encodes a member of the N-methyl-D-aspartate (NMDA) receptor family within the ionotropic glutamate receptor superfamily. The encoded protein is a subunit of the NMDA receptor ion channel which acts as an agonist binding site for glutamate. The NMDA receptors mediate a slow calcium-permeable component of excitatory synaptic transmission in the central nervous system. The NMDA receptors are heterotetramers of seven genetically encoded, differentially expressed subunits including NR1 (GRIN1), NR2 (GRIN2A, GRIN2B, GRIN2C, or GRIN2D) and NR3 (GRIN3A or GRIN3B). The early expression of this gene in development suggests a role in brain development, circuit formation, synaptic plasticity, and cellular migration and differentiation. Naturally occurring mutations within this gene are associated with neurodevelopmental disorders including autism spectrum disorder, attention deficit hyperactivity disorder, epilepsy, and schizophrenia. [provided by RefSeq, Aug 2017]
GRIN2B Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
  • developmental and epileptic encephalopathy, 27
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • intellectual disability, autosomal dominant 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.962 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRIN2BNM_000834.5 linkc.2172-441A>C intron_variant Intron 11 of 13 ENST00000609686.4 NP_000825.2
GRIN2BNM_001413992.1 linkc.2172-441A>C intron_variant Intron 12 of 14 NP_001400921.1
GRIN2BXM_005253351.3 linkc.-43-441A>C intron_variant Intron 1 of 3 XP_005253408.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRIN2BENST00000609686.4 linkc.2172-441A>C intron_variant Intron 11 of 13 1 NM_000834.5 ENSP00000477455.1

Frequencies

GnomAD3 genomes
AF:
0.514
AC:
78170
AN:
151934
Hom.:
20915
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.470
Gnomad AMI
AF:
0.456
Gnomad AMR
AF:
0.507
Gnomad ASJ
AF:
0.539
Gnomad EAS
AF:
0.985
Gnomad SAS
AF:
0.754
Gnomad FIN
AF:
0.570
Gnomad MID
AF:
0.455
Gnomad NFE
AF:
0.481
Gnomad OTH
AF:
0.528
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.515
AC:
78238
AN:
152052
Hom.:
20942
Cov.:
33
AF XY:
0.525
AC XY:
38992
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.470
AC:
19506
AN:
41472
American (AMR)
AF:
0.507
AC:
7745
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.539
AC:
1870
AN:
3468
East Asian (EAS)
AF:
0.985
AC:
5091
AN:
5170
South Asian (SAS)
AF:
0.755
AC:
3638
AN:
4818
European-Finnish (FIN)
AF:
0.570
AC:
6032
AN:
10574
Middle Eastern (MID)
AF:
0.452
AC:
132
AN:
292
European-Non Finnish (NFE)
AF:
0.481
AC:
32691
AN:
67954
Other (OTH)
AF:
0.530
AC:
1117
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1862
3724
5586
7448
9310
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
704
1408
2112
2816
3520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.408
Hom.:
1745
Bravo
AF:
0.506
Asia WGS
AF:
0.825
AC:
2865
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.71
CADD
Benign
13
DANN
Benign
0.76
PhyloP100
1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1806195; hg19: chr12-13723392; API